AAOS: Glucosamine Sulfate and Intraarticular HA Ineffective for Hip Osteoarthritis
The American Academy of Orthopedic Surgeons (AAOS) has recently published new clinical practice guidelines (CPG) for the treatment of hip osteoarthritis.
The guidelines do not support the use of glucosamine sulfate or intra-articular hyaluronic acid (HA) in the management of patients with hip osteoarthritis. According to AAOS, available evidence indicates none of these products performed better than placebo in improving function, reducing stiffness and decreasing joint pain. On the other hand, the guidelines strongly advocate the use of pre-surgical treatments such as corticosteroid injections, physiotherapy and non-narcotic drugs to reduce pain and improve function.
With respect to total hip arthroplasty (HA), the AAOS stated that there are no clinically significant differences in patient-oriented outcomes regarding hip surgery approach. It could be either anterior or posterior following total hip replacement (THR) surgery.
Moderate strength evidence supports that obese patients with symptomatic osteoarthritis of the hip, when compared to non-obese patients, may achieve lower absolute outcome scores but a similar level of patient satisfaction and relative improvement in pain and function after total hip arthroplasty.
Tags: osteoarthritis, hip osteoarthritis